Upstream Biosciences Inc. Begins Animal Efficacy Testing for Trypanosomiasis Treatment

VANCOUVER, BC--(Marketwire - September 15, 2008) - Upstream Biosciences Inc. (OTCBB: UPBS) announced today that it has begun animal efficacy testing in collaboration with Makerere University in Kampala, Uganda to evaluate its proprietary drug candidates as potential livestock and human treatments for Trypanosomiasis. Management anticipates that this research will lead to the selection of a drug candidate to treat Trypanosomiasis initially in livestock followed by a human treatment for the disease.

Back to news